Hoarding and treatment response in 38 nondepressed subjects with obsessive-compulsive disorder

Journal of Clinical Psychiatry

Volumn 59, Issue 8, 1998, Pages 420-425

  Black, Donald W ^a   Monahan, Patrick ^a   Gable, Janelle ^a   Blum, Nancee ^a   Clancy, Gerard ^a   Baker, Peggy ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIPRAMINE; FLUOXETINE; PAROXETINE;

ADULT; ARTICLE; BEHAVIOR THERAPY; CLINICAL ARTICLE; COGNITIVE THERAPY; COMPULSION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MALE; OBSESSION; ONSET AGE; ORAL DRUG ADMINISTRATION; PERSONALITY DISORDER; PRIORITY JOURNAL; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0031846537     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v59n0804     Document Type: Article

References (37)

1. Rasmussen SA, Eisen JL, Pato MT. Current issues in the pharmacologic management of obsessive compulsive disorder. J Clin Psychiatry 1993;54 (suppl 6):4-9
2. Alarcon RD, Libb JW, Spitler D. A predictive study of obsessive-compulsive disorder response to clomipramine. J Clin Psychopharmacol 1993;13: 210-213
3. Ravizza L, Barzega G, Bellino S, et al. Predictors of drug treatment response in obsessive-compulsive disorder. J Clin Psychiatry 1995;56: 368-373
4. Jenike MA, Baer L, Minichiello WE, et al. Concomitant obsessive-compulsive disorder and schizotypal personality disorder. Am J Psychiatry 1986;143:530-532
5. Baer L, Jenike MA, Black DW, et al. Effect of axis II diagnosis on treatment outcome with clomipramine in 54 patients with obsessive-compulsive disorder. Arch Gen Psychiatry 1992;49:862-866
6. McDougle CJ, Goodman WK, Leckman JF, et al. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder: a double-blind, placebo controlled study in patients with and without tics. Arch Gen Psychiatry 1994;51:302-308
7. Foa EB. Failure in treating obsessive-compulsives. Behav Res Ther 1979; 17:169-176
8. Keijsers GPJ, Hoogdvin CAL, Schaap CPDR. Predictors of treatment outcome in the behavioral treatment of obsessive-compulsive disorder. Br J Psychiatry 1994;165:781-786
9. DeVeaugh J, Katz R, Landau P, et al. Clinical predictors of treatment response in obsessive-compulsive disorder: exploratory analyses from multicenter trials of clomipramine. Psychopharmacol Bull 1990;26:54-59
10. Jenike MA, Buttolph L, Baer L, et al. Open trial of fluoxetine in obsessive-compulsive disorder. Am J Psychiatry 1989;146:909-911
11. Goodman WK, Price LH, Rasmussen SA, et al. Efficacy of fluvoxamine in obsessive-compulsive disorder: a double-blind comparison with placebo. Arch Gen Psychiatry 1989;46:36-44
12. Perse TL, Greist JH, Jefferson JW, et al. Fluvoxamine treatment of obsessive-compulsive disorder. Am J Psychiatry 1987;144:1543-1548
13. Tollefson GD, Rampey AH, Potvin JH, et al. A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 1994;51:559-567
14. Orloff LM, Battle MA, Baer L, et al. Long-term follow-up of 85 patients with obsessive-compulsive disorder. Am J Psychiatry 1994;151:441-442
15. Ackerman DL, Greenleaf S, Bystritsky A, et al. Predictors of treatment response in obsessive-compulsive disorder: multivariate analyses from a multicenter trial of clomipramine. J Clin Psychopharmacol 1994;14: 247-254
16. Leonard HL, Swedo SE, Lenane MC, et al. A 2-to 7-year follow-up study of 54 obsessive-compulsive children and adolescents. Arch Gen Psychiatry 1993;50:429-439
17. Thomsen PH. Obsessive-compulsive disorder in children and adolescents: predictors in childhood for long-term phenomenological course. Acta Psychiatr Scand 1995;92:255-259
18. Wheadon DE, Bushnell WD, Steiner M. A fixed-dose comparison of 20, 40, or 60 mg paroxetine to placebo in the treatment of obsessive-compulsive disorder. Presented at the 32nd annual meeting of the American College of Neuropsychopharmacology; 1993; Honolulu, Hawaii
19. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC: American Psychiatric Association; 1987
20. Spitzer RL, Williams JBW, Gibbon M. Structured Clinical Interview for DSM-III-R (SCID). New York, NY: Biometric Research, New York State Psychiatric Institute; 1989
21. Goodman WK, Price LR, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale, I: development, use, and reliability. Arch Gen Psychiatry 1989;46:1006-1011
22. Insel TR, Murphy DL, Cohen RM, et al. Obsessive-compulsive disorder: a double-blind trial of clomipramine and clorgyline. Arch Gen Psychiatry 1983;40:605-612
23. Hamilton M. Developing a rating scale for primary depressive illness. Br J Soc Psychol 1967;6:278-296
24. Foa EB, Wilson R. How to Overcome Your Obsessions and Compulsions. New York, NY: Bantam Books; 1991
25. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976:218-222
26. Hodgson RJ, Rachman S. Obsessive-compulsive complaints. Behav Res Ther 1977;15:389-395
27. Derogatis LR. Symptom Checklist-90 (Revised): Administration, Scoring, and Procedures Manual, I. Baltimore, Md: Clinical Psychometric Research; 1977
28. Pilowsky I, Spence ND. Manual for the Illness Behavior Questionnaire. 2nd ed. Adelaide, Australia: Department of Psychiatry, University of Adelaide; 1983
29. Pfohl B, Zimmerman M, Blum N. Structured Interview for DSM-III-R Personality Disorders. Iowa City, Iowa: Department of Psychiatry, University of Iowa; 1987
30. Hyler SE, Reider RO, Spitzer RL. PDQ-R: Personality Diagnostic Questionnaire-Revised. New York, NY: New York State Psychiatric Institute; 1987
31. Andreasen NC, Endicott J, Spitzer RL, et al. The family history method using diagnostic criteria: reliability and validity. Arch Gen Psychiatry 1977;34:1229-1235
32. Endicott J, Spitzer RL, Fleiss JL, et al. The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976;33:766-771
33. Rasmussen S, Eisen JL. Phenomenology of OCD: clinical subtypes, heterogeneity, and co-existence. In: Zohar J, Insel T, Rasmussen S, eds. The Psychobiology of Obsessive-Compulsive Disorder. New York, NY: Springer Publishing; 1991:13-43
34. Miguel EC, Baer L, Coffey BJ, et al. Phenomenological differences of repetitive behaviors in obsessive-compulsive disorder and Tourette's syndrome. Br J Psychiatry 1997;170:140-145
35. Leckman JF, Grice DE, Boardman J, et al. Symptoms of obsessive-compulsive disorder. Am J Psychiatry 1997;154:911-917
36. Jenike MA. Management of patients with treatment-resistant obsessive-compulsive disorder. In: Pato MT, Zohar J, eds. Current Treatments of Obsessive-Compulsive Disorder. Washington, DC: American Psychiatric Press; 1991:135-155
37. Emmelkamp PMG, Visser S, Hoekstra RJ. Cognitive therapy versus exposure in vivo in the treatment of obsessive-compulsive disorder. Cognitive Ther Res 1988;12:103-114